Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-116057·Dogwood Therapeutics, Inc.
Schedule 13D ownership disclosure
DOGWOOD THERAPEUTICS INC
Common Stock, $0.0001 par value · CUSIP: 92829J203
Event date: 2025-11-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sealbond LimitedReported CIK 0002040446
Shares: 21,822,333.00 · Class: 73.4%
- CK Life Sciences Int'l., (Holdings) Inc.
Shares: 24,664,971.00 · Class: 83.0%
- Conjoint Inc.
Shares: 2,842,638.00 · Class: 9.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-116057
- Form type
- SCHEDULE 13D/A
- Filer
- Dogwood Therapeutics, Inc.
- CIK
- CIK 1818844
- Filed
- Nov 25, 2025
- Reporting period
- Nov 21, 2025
- Description
- Schedule 13D beneficial ownership